Advanced Life Science Institute is Biotechnology in Japan that focus on viral hepatitis business. Founded in 1999. They cover business area such as developer, viral hepatitis diagnostic agent, pharmaceutical, biotechnology, patented diagnostic agent, HCV antibody, HCV antigen, high-sensitivity HBV antigen, lung small cell cancer diagnostic drug.
1999
( 27 years old in 2026 )
Viral Hepatitis
-
51 Komiyamachi
Hachioji-shi
Tokyo, 192-0031
Japan
Private
developerviral hepatitis diagnostic agentpharmaceuticalbiotechnologypatented diagnostic agentHCV antibodyHCV antigenhigh-sensitivity HBV antigenlung small cell cancer diagnostic drug
* We use standard office opening hours in near Advanced Life Science Institute's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Advanced Life Science Institute is Biotechnology business from Japan that founded in 1999 (27 years old in 2026), Advanced Life Science Institute business is focusing on Viral Hepatitis.
Advanced Life Science Institute headquarter office and corporate office address is located in 51 Komiyamachi Hachioji-shi Tokyo, 192-0031 Japan.
Advanced Life Science Institute was founded in Japan.
In 2026, Advanced Life Science Institute is currently focus on viral hepatitis sector.
Above is snippet of Google Trends for "viral hepatitis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Advanced Life Science Institute, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.